By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Heat Biologics 

Atlantic Center
119 Washington Avenue, Suite 401
Miami Beach  Florida  33139  U.S.A.
Phone: 305-432-4684 Fax: n/a



Company News
Heat Biologics Completes Enrollment Of Phase 1 Clinical Trial Of Vesigenurtacel-L For The Treatment Of Bladder Cancer Required To Advance To Phase 2 10/2/2014 8:09:18 AM
Heat Biologics To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco On Tuesday, October 7, 2014 9/30/2014 7:32:10 AM
Heat Biologics Commences Patient Dosing In Phase 2 Study Of Viagenpumatucel-L For The Treatment Of Non-Small Cell Lung Cancer 9/18/2014 7:44:29 AM
Heat Biologics To Present And Webcast At Two Investor Conferences In September 9/4/2014 10:08:56 AM
Heat Biologics Closes On Up To $7.5 Million Secured Term Loan Facility 8/25/2014 7:50:07 AM
Heat Biologics Reports 2014 Second Quarter Financial Results 8/14/2014 7:32:47 AM
Heat Biologics Amends Bladder Cancer Protocol For Early Advancement Into Phase 2 Clinical Studies 8/4/2014 8:19:56 AM
Heat Biologics Receives Green Light To Expand Enrollment Of Its Phase 1/2 Study Of HS-410 In Bladder Cancer Based On Encouraging Preliminary Safety Results 5/30/2014 9:45:03 AM
Heat Biologics To Present At The LD MICRO Fourth Invitational Conference On Wednesday, June 4, 2014 5/30/2014 9:36:52 AM
Heat Biologics To Present At The Third Annual Marcum MicroCap Conference On Thursday, May 29, 2014 5/23/2014 9:35:32 AM